Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care
- PMID: 18647461
Decentralised management of drug-resistant tuberculosis (MDR- and XDR-TB) in South Africa: an alternative model of care
Abstract
Setting: A growing number of cases of extensively drug-resistant tuberculosis (XDR-TB) have been reported from KwaZulu-Natal, South Africa.
Objective: To propose an alternative model to centralised care that can be implemented to alleviate the current emergency.
Discussion: The current failing TB programme could be improved by borrowing strategies such as decentralisation of care, treatment expertise, high levels of treatment adherence and successful outcomes, all of which have been successfully implemented in the human immunodeficiency virus programme. Patients with multidrug-resistant or XDR-TB could be admitted to institutions closer to their homes for treatment with subsequent discharge to home-based care.
Conclusion: The longer we support a failed system or wait for a perfect solution, the more the current devastation will continue to grow.
Similar articles
-
Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa.Int J Tuberc Lung Dis. 2012 Feb;16(2):209-15. doi: 10.5588/ijtld.11.0401. Int J Tuberc Lung Dis. 2012. PMID: 22236922 Free PMC article.
-
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. eCollection 2015 Sep. PLoS Med. 2015. PMID: 26418737 Free PMC article.
-
Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.Int J Tuberc Lung Dis. 2015 Feb;19(2):163-71. doi: 10.5588/ijtld.14.0369. Int J Tuberc Lung Dis. 2015. PMID: 25574914 Free PMC article.
-
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4. Infect Genet Evol. 2012. PMID: 21839855 Review.
-
Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.J Infect Dis. 2007 Dec 1;196 Suppl 3:S482-90. doi: 10.1086/521121. J Infect Dis. 2007. PMID: 18181698 Review.
Cited by
-
Initiation, scale-up and outcomes of the Cambodian National MDR-TB programme 2006-2016: hospital and community-based treatment through an NGO-NTP partnership.BMJ Open Respir Res. 2018 Jun 4;5(1):e000256. doi: 10.1136/bmjresp-2017-000256. eCollection 2018. BMJ Open Respir Res. 2018. PMID: 29955361 Free PMC article.
-
Extensively drug-resistant tuberculosis: a new face to an old pathogen.Annu Rev Med. 2009;60:307-20. doi: 10.1146/annurev.med.60.053107.103955. Annu Rev Med. 2009. PMID: 19630575 Free PMC article. Review.
-
Towards understanding the drivers of policy change: a case study of infection control policies for multi-drug resistant tuberculosis in South Africa.Health Res Policy Syst. 2017 May 30;15(1):41. doi: 10.1186/s12961-017-0203-y. Health Res Policy Syst. 2017. PMID: 28558838 Free PMC article.
-
Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis.Glob Health Res Policy. 2016 Aug 2;1:10. doi: 10.1186/s41256-016-0010-y. eCollection 2016. Glob Health Res Policy. 2016. PMID: 29202059 Free PMC article.
-
Nano/Microfluidics for diagnosis of infectious diseases in developing countries.Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):449-57. doi: 10.1016/j.addr.2009.11.016. Epub 2009 Nov 30. Adv Drug Deliv Rev. 2010. PMID: 19954755 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
